Guangzhou

Led by Legend Capital, PureFDA Secures Over CNY100 million in the Series B Round

Retrieved on: 
Thursday, November 10, 2022

HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.

Key Points: 
  • HONG KONG, Nov 10, 2022 - (ACN Newswire) - Recently, PureFDA Medical Technology (Guangzhou) Co., LTD. (hereinafter referred to as "PureFDA") announced the completion of the Series B round of financing of over CNY100 million, which was led by Legend Capital and followed by the existing shareholder Bayland Capital.
  • The company's service network has spread to 10 countries and regions worldwide, including the United States, Germany, Italy, Spain, Switzerland and Poland.
  • Rooted in China, Legend Capital participated in the rise of many world-leading companies by solid investment coverage and systematic post-investment value-add.
  • As a UNPRI signatory since November 2019, Legend Capital is among the first group of top VC/PE firms in China to join the initiative.

Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round

Retrieved on: 
Thursday, October 20, 2022

HONG KONG, Oct 20, 2022 - (ACN Newswire) - VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital.

Key Points: 
  • HONG KONG, Oct 20, 2022 - (ACN Newswire) - VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as "VectorBuilder"), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital.
  • The company provides services such as scientific research and clinical carrier CRO, gene-drug CDMO and gene delivery IP out-licensing, covering the entire field of life science and gene medicine.
  • VectorBuilder has become a pioneer in the entire gene delivery industry chain by empowering basic scientific research and accelerating the clinical application of gene drugs.
  • Jeff Wang, Managing Director of Legend Capital, said: "VectorBuilder is the world's leading gene delivery company, providing full-chain solutions from basic scientific research to clinical application of gene delivery.

Visionary Education Technology Holdings Group Inc. to Acquire 100% Equity Interest in Griggs International Academy China Co. Ltd.

Retrieved on: 
Thursday, July 21, 2022

Griggs China is a private consulting and investment holding company in Hong Kong offering United States K-12 diploma programs and services of Griggs International Academy USA at four locations in China.

Key Points: 
  • Griggs China is a private consulting and investment holding company in Hong Kong offering United States K-12 diploma programs and services of Griggs International Academy USA at four locations in China.
  • Under the Sale and Purchase Agreement, the Company has agreed to acquire the remaining 10% equity interest in Griggs China from its shareholders for US$50,000.
  • About Griggs International Academy China Co. Ltd.
    Griggs International Academy China Co. Ltd. is a private consulting and investment holding company offering Griggs International Academy USA K-12 diploma programs and services in China and all its subsidiaries, including Griggs (Guangzhou) International Education Consulting Com.
  • AboutVisionary Education Technology Holdings Group Inc.
    Visionary Education Technology Holdings Group Inc., headquartered in Markham, Canada, is a private education provider located in Canada that offers high-quality education resources to students around the globe.

Colson Medical Announces Hjalmar Pompe van Meerdervoort as New Acumed President

Retrieved on: 
Wednesday, June 1, 2022

HILLSBORO, Ore., June 1, 2022 /PRNewswire-PRWeb/ -- Colson Medical, LLC announces Hjalmar Pompe van Meerdervoort as President, Acumed, effective June 1. Pompe van Meerdervoort succeeds Sharon Wolfington, who will transition into a new advisory role for Colson Medical, LLC. After nearly five years at Acumed, Wolfington chose to pursue other professional and personal opportunities.

Key Points: 
  • Colson Medical, LLC announces the appointment of Hjalmar Pompe van Meerdervoort to the role of president, Acumed, effective June 1.
  • HILLSBORO, Ore., June 1, 2022 /PRNewswire-PRWeb/ -- Colson Medical, LLC announces Hjalmar Pompe van Meerdervoort as President, Acumed, effective June 1.
  • Pompe van Meerdervoort succeeds Sharon Wolfington, who will transition into a new advisory role for Colson Medical, LLC.
  • Pompe van Meerdervoort brings extensive global healthcare experience with his more than 25-year career in orthopaedics and medical devices.

Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms

Retrieved on: 
Wednesday, March 30, 2022

The strategic alliance with Lian-Ou Health is one of the Companys approaches to stay competitive with the fast-evolving digital economy in China and tackle the challenges associated with the COVID-19 pandemic by exploring solutions in digital marketing and sales.

Key Points: 
  • The strategic alliance with Lian-Ou Health is one of the Companys approaches to stay competitive with the fast-evolving digital economy in China and tackle the challenges associated with the COVID-19 pandemic by exploring solutions in digital marketing and sales.
  • Mr. Hanhui Li, Vice President of Lian-Ou Health, said, As a practitioner of pharmaceutical Direct-To-Consumer (DTC) digital marketing and sales strategy, Lian-Ou Health has been exploring marketing strategies to adapt to changes in the pharmaceutical market.
  • Recent changes in the macro-environment and consumer preferences drive the Company to empower its brands through digital marketing and sales on e-commerce platforms.
  • About Lian-Ou Health Pharmaceutical (Guangzhou) Co., Ltd.
    Lian-Ou Health is a high-tech company focusing on medical treatment, technology, operation, sales and services.

EHang Reports Third Quarter 2021 Unaudited Financial Results

Retrieved on: 
Thursday, December 2, 2021

GUANGZHOU, China, Dec. 02, 2021 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform company, today announced its unaudited financial results for the third quarter ended September 30, 2021.

Key Points: 

EHang 216 Autonomous Aerial Vehicle Completes Debut Flight Demo in Bali, Indonesia

Retrieved on: 
Monday, November 29, 2021

GUANGZHOU, China, Nov. 29, 2021 (GLOBE NEWSWIRE) -- The world's leading autonomous aerial vehicle (AAV) EHang 216 completed its debut flight demonstration for aerial sightseeing in the world-famous tourism hotspot of Bali, Indonesia.

Key Points: 
  • GUANGZHOU, China, Nov. 29, 2021 (GLOBE NEWSWIRE) -- The world's leading autonomous aerial vehicle (AAV) EHang 216 completed its debut flight demonstration for aerial sightseeing in the world-famous tourism hotspot of Bali, Indonesia.
  • The EHang 216 demonstrated a five-minute autonomous flight at the scenic Villa Blackstone Beach, Bali.
  • Prior to the flight demo, the Directorate General of Civil Aviation of the Republic of Indonesia issued the Special Certificate of Airworthiness for the EHang 216 AAV, enabling it to be the Indonesias first passenger-grade AAV approved for a public unmanned flight demo.
  • Hu Huazhi, Founder, Chairman and CEO of EHang, said, The successful flight demo fully showcased EHang 216s potential for efficient island hopping and air transportation.

EHang Appoints PwC as its New Auditor

Retrieved on: 
Monday, November 29, 2021

PwC succeeds Ernst & Young Hua Ming LLP (EY), which previously was the independent registered accounting firm providing audit services to the Company.

Key Points: 
  • PwC succeeds Ernst & Young Hua Ming LLP (EY), which previously was the independent registered accounting firm providing audit services to the Company.
  • EHang (Nasdaq: EH) is the world's leading autonomous aerial vehicle (AAV) technology platform company.
  • EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions.
  • This press release contains statements that may constitute forward-looking statements pursuant to the safe harbor provisions of the U.S.

Fanhua Launches Customized Whole Life and Annuity Insurances with Sinatay

Retrieved on: 
Monday, November 29, 2021

GUANGZHOU, China, Nov. 28, 2021 (GLOBE NEWSWIRE) -- Fanhua Inc. (Fanhua or the Company) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it has partnered with Sinatay Life Insurance Co., Ltd (Sinatay) to launch two customized products, including Fanhua-Sinatay Legacy, a whole life insurance plan and Fanhua-Sinatay Yixiang, an annuity insurance plan.

Key Points: 
  • GUANGZHOU, China, Nov. 28, 2021 (GLOBE NEWSWIRE) -- Fanhua Inc. (Fanhua or the Company) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it has partnered with Sinatay Life Insurance Co., Ltd (Sinatay) to launch two customized products, including Fanhua-Sinatay Legacy, a whole life insurance plan and Fanhua-Sinatay Yixiang, an annuity insurance plan.
  • Fanhua-Sinatay Yixiang is a pension annuity that is designed to help hedge against inflation and secure a lifetime stable annuity income stream.
  • This is another major breakthrough of Fanhua in tapping into the savings insurance segment and echoes our commitment to keeping innovating our ideas and products to better meet evolving market needs.
  • Sinatay Life Insurance Co., Ltd., founded in 2007, has a registered capital of RMB5 billion.